Barrington lowered the firm’s price target on Option Care Health (OPCH) to $32 from $40 and keeps an Outperform rating on the shares following the Q3 report. The firm cites the company’s commentary related to the Stelara issue for the target cut.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OPCH:
- Option Care Health downgraded to Hold from Buy at Jefferies
- Option Care Health Reports Q3 Revenue Surge Amid Challenges
- Option Care Health downgraded to Neutral at BofA on Stelara risks
- Option Care Health downgraded to Neutral from Buy at BofA
- Alphabet, AMD report Q3 earnings beats: Morning Buzz
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
